SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decent increase of about 33.70% in the sales to Rs. 78095.00 millions was observed for the quarter ended June 2025. The sales figure stood at Rs. 58412.00 millions during the year-ago period.The Net Profit of the company vaulted to 108.95% to Rs. 29612.00  millions from Rs. 14172.00 millions in the previous quarter.The company reported a good operating profit of 42353.00 millions compared to 21708.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 78095.00 58412.00 33.70 78095.00 58412.00 33.70 231154.00 194838.00 18.64
Other Income 3983.00 2178.00 82.87 3983.00 2178.00 82.87 10034.00 8623.00 16.36
PBIDT 42353.00 21708.00 95.10 42353.00 21708.00 95.10 83852.00 67887.00 23.52
Interest 192.00 71.00 170.42 192.00 71.00 170.42 1099.00 218.00 404.13
PBDT 42161.00 21637.00 94.86 42161.00 21637.00 94.86 82753.00 67669.00 22.29
Depreciation 2798.00 2498.00 12.01 2798.00 2498.00 12.01 10394.00 9756.00 6.54
PBT 39363.00 19139.00 105.67 39363.00 19139.00 105.67 72359.00 57913.00 24.94
TAX 9751.00 4967.00 96.32 9751.00 4967.00 96.32 18865.00 14493.00 30.17
Deferred Tax 334.00 301.00 10.96 334.00 301.00 10.96 960.00 875.00 9.71
PAT 29612.00 14172.00 108.95 29612.00 14172.00 108.95 53494.00 43420.00 23.20
Equity 835.00 834.00 0.12 835.00 834.00 0.12 834.00 834.00 0.00
PBIDTM(%) 54.23 37.16 45.93 54.23 37.16 45.93 36.28 34.84 4.11

Dr. Reddys Lab Share Price

1220.75 -11.50 (-0.93%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×